Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

Wang X, Goldstein D, Crowe PJ, Yang JL

OncoTargets and Therapy 2016, 9:5461-5473

Published Date: 6 September 2016